Explore new ways of in-depth integration of industry, university and research, and expand new paths for the transformation of scientific and technological achievements
Chengdu High-tech Medical Association visited Chengdu Medical College to discuss a new path for the construction of a transformation platform for scientific and technological achievements
On the afternoon of October 29, 2021, Zeng Bin, Vice President and Secretary-General of Chengdu High-tech Medical Association, led a team of related personnel to inspect and visit the University Science and Technology Park (Fengyun Valley) of Chengdu Medical College. Zhang Tao, the director of the Science and Technology Department of Chengdu Medical College and the deputy dean of the School of Innovation and Entrepreneurship, etc., warmly received and accompanied the visit. Afterwards, the two parties conducted in-depth exchanges on issues such as exploring the deep integration of production, teaching and research, expanding the transformation of scientific and technological achievements, and innovation and entrepreneurship services.
Tang Yan, director of the University Science Park Management Office of Chengdu Medical College, introduced the current operation mode and work results of the medical innovation project of the Chengdu Medical University Science Park, and then Director Zhang Tao once again explained the current development direction of the Chengdu Medical University Science and Technology Park in the greater Chengdu area Under the premise of the competitive advantages of various medical schools in China, how to differentiate their development and find an innovative path suitable for Chengdu Medical College. In addition, Director Zhang Tao said that colleges and universities are vigorously promoting the transformation of technological innovation and the rapid maturity of start-ups. They hope to use the advantages of external platforms to make up for each other's shortcomings, complement each other, and jointly explore new ways of in-depth integration of industry, university and research, and assist Institutional start-up business development.
Then, under the leadership of Director Zhang Tao and other people, the Chengdu High-tech Medical Association visited the scientific research experimental center of Chengdu Medical College, where they exchanged ideas with experts from various disciplines and universities to further understand how researchers are in the process of exporting scientific research results to the market. Needs and pain points. Director Zhang Tao once again stated the current needs of colleges and universities for the transformation of scientific and technological achievements, and conducted in-depth explorations and explorations on the introduction and use of the advantages of third-party platforms in the transformation of scientific and technological achievements, scientific research management, scientific and technological industry cultivation services, and financial services support for the transformation of achievements. Docking.
Finally, Chengdu High-tech Medical Association, accompanied by Wang Jiandong, deputy director of the Science and Technology Department of Chengdu Medical College, visited the GCP Center of the First Affiliated Hospital of Chengdu Medical College. And Zheng Lingli, director of the Pharmacy Department of the First Affiliated Hospital of Chengdu Medical College and director of the GCP Center, introduced the current development status of the GCP Center of the First Affiliated Hospital of Chengdu Medical College. The two parties hope to have further communication and cooperation in the construction of regional ethics committees and regional GCP alliances.
Through this visit, Chengdu High-tech Medical Association and Chengdu Medical College have a lot of similarities in the transformation of scientific and technological achievements. It is believed that after in-depth communication and negotiation, the two parties will work together and commit to the transformation of scientific research and innovation results. The development of the big health industry.
